1-4 of 4
N. Schmitz, MD
Close
Sort by
Journal Articles

Allogeneic Stem Cell Transplantation in Angioimmunoblastic T-Cell Lymphoma (AITL): A Retrospective Survey from the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT).

Charalampia Kyriakou, MD, C. Canals, MD, G. Taghipour, J. Finke, MD, H. Kolb, MD, A. Goldstone, MD, A. Sureda, MD, N. Schmitz, MD
Journal: Blood
Blood (2007) 110 (11): 3042.
https://doi.org/10.1182/blood.V110.11.3042.3042
Published: 2007
Journal Articles

Allogeneic Stem Cell Transplantation (Allo-SCT) in the Management of Advanced Waldenstrom’s Macroglobulinemia (WM).

Charalampia Kyriakou, MD, C. Canals, MD, A. Sureda, MD, G. Taghipour, J. Cornelissen, MD, R. Willemze, MD, G. Socie, MD, H. Greinix, MD, J. Kienast, MD, R. Hamladji, MD, M. Kazmi, MD, P. Jacobs, MD, N. Schmitz, MD
Journal: Blood
Blood (2007) 110 (11): 619.
https://doi.org/10.1182/blood.V110.11.619.619
Published: 2007
Journal Articles

The Role of Autologous Stem Cell Transplantation (ASCT) in Patients with Advanced Waldenström’s Macroglobulinemia.

Charalampia Kyriakou, MD, C. Canals, MD, A. Sureda, MD, G. Taghipour, C. Gisselbrecht, MD, P. Mazza, MD, E. Montserrat, MD, N. Niederwieser, MD, K. Indrak, MD, A. Kolbe, MD, P. Biron, MD, A. Levis, MD, A. Goldstone, MD, N. Schmitz, MD
Journal: Blood
Blood (2007) 110 (11): 941.
https://doi.org/10.1182/blood.V110.11.941.941
Published: 2007
Journal Articles

Efficacy of Rituximab Combined in Salvage- and High Dose-Therapy (HDT) for Patients with Relapsed NHL; Interim Analysis of a Multicenter Phase II Study.

G. Hess, MD, T. Flohr, MD, N. Frickhofen, MD, H. Wolf, MD, M. Gramatzki, MD, H. Link, MD, N. Peter, MD, N. Basara, MD, N. Schmitz, MD, A. Banat, MD, M. Kneba, MD, C. Huber, MD, G. Derigs, MD
Journal: Blood
Blood (2004) 104 (11): 1325.
https://doi.org/10.1182/blood.V104.11.1325.1325
Published: 2004